Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record.

Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study

MAHALATI, KAMRAN, BELITSKY, PHILIP, WEST, KENNETH, KIBERD, BRYCE, FRASER, ALBERT, SKETRIS, INGRID, MACDONALD, ALAN S., MCALISTER, VIVIAN, LAWEN, JOSEPH·2001·Journal of the American Society of Nephrology

Abstract

Abstract.: Neoral dosing is traditionally based on cyclosporine (CyA) trough levels (C 0). Four-h area under the curve (AUC 0-4) for Neoral in the early posttransplantation period was shown previously to have a better correlation to acute rejection (AR) and CyA nephrotoxicity (CyANT), compared with C 0. An AUC 0-4 range of 4400 to 5500 μg/h per L during the first week was associated with the lowest AR and CyANT. This article describes a prospective study to assess the feasibility, safety, and efficacy of dosing Neoral solely by AUC 0-4 monitoring, regardless of C 0, in the first 3 mo after kidney transplantation. Fifty-nine kidney transplant recipients received Neoral-based triple immunosuppression. AUC 0-4 was measured on days 3, 5, 7, 10, and 14 and weeks 3, 4, 6, and 8, then monthly. Target AUC 0-4 was 4400 to 5500 μg/h per L. Dose was adjusted by percentage difference from target AUC 0-4. Ninety-four percent of AUC were performed on the scheduled day or close to it. No patients had CyANT while AUC 0-4 was in target range. Four patients had reversible CyANT with AUC 0-4 > 5500. Only 1 of 33 patients (3%) who achieved and maintained AUC 0-4 > 4400 by day 3 posttransplantation had AR, whereas 10 of 22 (45%) of those with day 3 to 5 AUC 0-4 < 4400 had AR (P = 0.0002). In logistic regression analysis, higher early AUC 0-4 was the only significant variable associated with lower serum creatinine at 3 mo. Neoral dose monitoring by AUC 0-4 is a potentially valuable tool for optimizing Neoral immunosuppression. Attainment of a target range of 4400 to 5500 μg/h per L for AUC 0-4 early after transplantation has been demonstrated to reduce significantly the risk of AR and CyANT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.v124828

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 168

Metadata

Authors
MAHALATI, K., BELITSKY, P., WEST, K., KIBERD, B., FRASER, A., SKETRIS, I., MACDONALD, A. S., MCALISTER, V., & LAWEN, J.
Venue
Journal of the American Society of Nephrology
Published
2001-04
Volume
12
Issue
4
Pages
828-833
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2148715165
Cited by
168
References
0
FWCI
16.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study. https://app.cochat.ai/papers/10.1681/asn.v124828
The paper
MAHALATI, K., BELITSKY, P., WEST, K., KIBERD, B., FRASER, A., SKETRIS, I., MACDONALD, A. S., MCALISTER, V., & LAWEN, J. (2001). Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v124828

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.